Taxotere Plus Weekly Navelbine and G-CSF: A Study in Stage IV Breast Cancer
Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
The two drugs used to treat metastatic breast cancer in this study may perform better when
used together than when used separately. The use of another drug that prevents the most
common side effect of the two-drug combination permits the delivery of both agents at closer
to the "full" dose for either when used alone. We hypothesize that the two-drug combination
used with G-CSF support will be more effective and less toxic than other standard regimens
for the treatment of metastatic breast cancer.